
Aman Drugs Private Limited
About Aman Drugs Private Limited
Data last updated:
Aman Drugs Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 February 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2005PTC133070. Its GSTIN is 07AAFCA3383A1Z3 (Delhi). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹6.5 Lakh. It is led by directors including Krishna Sachan and Pradip Sachan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.190 B – 3 (Basement) Functional Industrial Estate Patparganj, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.25 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹5.98 Lakh (net margin 1.4%) and EBITDA of ₹11.96 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 4% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹9.83 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aman Drugs Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.190 B – 3 (Basement) Functional Industrial Estate Patparganj, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aman Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aman Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aman Drugs Private Limited, buy the company report.
Financials of Aman Drugs Private Limited
FY 2024 filings availableAman Drugs Private Limited reported revenue of ₹4.25 Cr (down 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 30% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.96 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.98 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aman Drugs Private Limited, buy the company report.
Board of directors of Aman Drugs Private Limited
Aman Drugs has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Sachan | Director | 16 Feb 2005 | 21 Years 9 Months | Current |
| Pradip Sachan Also directs: Avenue Pharma Private Limited, Psa Drugs LLP, Lunaris Pharma Private Limited and 1 more | Director | 16 Feb 2005 | 21 Years 9 Months | Current |
| Savitri Devi | Director | 16 Feb 2005 | 21 Years 9 Months | Current |
| Shalini Sachan | Director | 16 Feb 2005 | 21 Years 9 Months | Current |
| Arun Kumar Sachan Also directs: Avenue Pharma Private Limited | Director | 08 Apr 2016 | 10 Years 7 Months | Current |
Peer comparison
Aman Drugs Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alkans Pharmaceuticals Private Limited | ₹4.27 Cr (FY 2025) | 42.0% | Lucknow, Uttar Pradesh, India | |||
| Resante Life Sciences Private Limited | ₹4.25 Cr (FY 2025) | 32.0% | Chennai, Tamil Nadu, India | |||
| A.V.R.Tradechem (India) Private Limited | ₹4.25 Cr (FY 2025) | 1.0% | Kolkata, West Bengal, India | |||
| Aman Drugs Private Limitedthis company | ₹4.25 Cr (FY 2025) | ₹5.98 Lakh | 1.4% | -30.0% | 3 | Delhi, India |
| Miotic Pharmaceutical Private Limited | ₹4.25 Cr (FY 2025) | 42.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Aman Drugs Private Limited, buy the company report.
Auditor
Aman Drugs Private Limited is audited by ANUPAM & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANUPAM & ASSOCIATES | FY 2023 | 088473 |
Shareholding
The shareholding of Aman Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aman Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Aug 2016 | 100054574 | Others | ₹3 Lakh | Satisfied | |
| 21 May 2012 | 10365596 | Standard Chartered Bank | ₹3.3 Cr | Satisfied | |
| 21 May 2012 | 10365584 | Standard Chartered Bank | ₹6.5 Cr | Satisfied |
To see the full charge records of Aman Drugs Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Aman Drugs Private Limited has 1 court case on record: 1 filed by Aman Drugs. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South Twenty Four Parganas, West Bengal | Civil suit | Filed by the company against an individual | Disposed |
To see the full case history of Aman Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aman Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aman Drugs Private Limited has a workforce of 3 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 3 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Aman Drugs Private Limited, buy the company report.
GST
Aman Drugs has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCA3383A1Z3 | Delhi | Active | 01 Jul 2017 |
| 19AAFCA3383A1ZY | West Bengal | Active | 01 Jul 2017 |
| 09AAFCA3383A2ZY | Uttar Pradesh | Active | 23 May 2018 |
To see the full GST registrations and return filing status of Aman Drugs Private Limited, buy the company report.
Recent activity
Aman Drugs Private Limited has 8 board changes on record since 2005: 5 appointments and 3 cessations. The latest: Aman Sachan ceased to be Additional Director on 02 Aug 2017.
6 earlier events are in the company report.
Frequently asked questions
Aman Drugs is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 February 2005 (21+ years old) and is registered under CIN U24233DL2005PTC133070.
Aman Drugs has 5 current directors:
- Krishna Sachan - Director
- Pradip Sachan - Director
- Savitri Devi - Director
- Shalini Sachan - Director
- Arun Kumar Sachan - Director
The latest financial statements of Aman Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Aman Drugs is 07AAFCA3383A1Z3, registered in Delhi. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 19AAFCA3383A1ZY (West Bengal), 09AAFCA3383A2ZY (Uttar Pradesh).
The CIN (Corporate Identification Number) of Aman Drugs is U24233DL2005PTC133070. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aman Drugs has 1 court case on record: 1 filed by the company.
Aman Drugs was incorporated on 16 February 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Aman Drugs by revenue are Alkans Pharmaceuticals Private Limited, Resante Life Sciences Private Limited, A.V.R.Tradechem (India) Private Limited, Miotic Pharmaceutical Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Aman Sachan ceased to be Additional Director on 02 Aug 2017. Arun Kumar Sachan ceased to be Additional Director on 26 Sep 2016. Arun Kumar Sachan was appointed as Director on 08 Apr 2016. Aman Drugs has 8 board changes on record in total.
The registered office of Aman Drugs is at Plot No.190 B – 3 Basement Functional Industrial Estate Patparganj, Delhi, India – 110092.
Aman Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

